Global HIV Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 222 pages | ID: G45AAAF06334EN
Bosson Research

Abstracts

Report Overview

HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.

This report provides a deep insight into the global HIV Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global HIV Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV Therapy market in any manner.

Global HIV Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

ViiV Healthcare

Gilead Sciences

Inc.

GlaxoSmithKline Plc

Merck Sharp & Dohme Corp.

Bristol-Myers Squibb Company

Janssen Pharmaceuticals

Inc.

Boehringer Ingelheim International GmbH

AbbVie Inc.

Genentech

Inc.

Mylan N.V.

Market Segmentation (by Type)

Integrase Inhibitors

Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Combination HIV Medicines

Others

Market Segmentation (by Application)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the HIV Therapy Market
• Overview of the regional outlook of the HIV Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the HIV Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of HIV Therapy
1.2 Key Market Segments
1.2.1 HIV Therapy Segment by Type
1.2.2 HIV Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global HIV Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global HIV Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global HIV Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global HIV Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global HIV Therapy Product Life Cycle
3.3 Global HIV Therapy Sales by Manufacturers (2020-2025)
3.4 Global HIV Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 HIV Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global HIV Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers HIV Therapy Manufacturing Sites, Area Served, Product Type
3.8 HIV Therapy Market Competitive Situation and Trends
3.8.1 HIV Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest HIV Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HIV Therapy Industry Chain Analysis
4.1 HIV Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of HIV Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global HIV Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to HIV Therapy Market
5.7 ESG Ratings of Leading Companies
6 Global HIV Therapy Market by Region
6.1 Global HIV Therapy Market Size by Region
6.1.1 Global HIV Therapy Market Size by Region
6.1.2 Global HIV Therapy Market Size Market Share by Region
6.2 Global HIV Therapy Sales by Region
6.2.1 Global HIV Therapy Sales by Region
6.2.2 Global HIV Therapy Sales Market Share by Region
7 North America Market Overview
7.1 North America HIV Therapy Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America HIV Therapy Market Size by Type
7.3 North America HIV Therapy Market Size by Application
8 Europe Market Overview
8.1 Europe HIV Therapy Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe HIV Therapy Market Size by Type
8.3 Europe HIV Therapy Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific HIV Therapy Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific HIV Therapy Market Size by Type
9.3 Asia-Pacific HIV Therapy Market Size by Application
10 South America Market Overview
10.1 South America HIV Therapy Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America HIV Therapy Market Size by Type
10.3 South America HIV Therapy Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa HIV Therapy Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa HIV Therapy Market Size by Type
11.3 Middle East and Africa HIV Therapy Market Size by Application
12 HIV Therapy Market Production by Region
12.1 Global Production of HIV Therapy by Region(2020-2025)
12.2 Global HIV Therapy Revenue Market Share by Region (2020-2025)
12.3 Global HIV Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America HIV Therapy Production
12.4.1 North America HIV Therapy Production Growth Rate (2020-2025)
12.4.2 North America HIV Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe HIV Therapy Production
12.5.1 Europe HIV Therapy Production Growth Rate (2020-2025)
12.5.2 Europe HIV Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan HIV Therapy Production (2020-2025)
12.6.1 Japan HIV Therapy Production Growth Rate (2020-2025)
12.6.2 Japan HIV Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China HIV Therapy Production (2020-2025)
12.7.1 China HIV Therapy Production Growth Rate (2020-2025)
12.7.2 China HIV Therapy Production, Revenue, Price and Gross Margin (2020-2025)
13 HIV Therapy Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global HIV Therapy Sales Market Share by Type (2020-2033)
13.3 Global HIV Therapy Market Size Market Share by Type (2020-2033)
13.4 Global HIV Therapy Price by Type (2020-2033)
14 HIV Therapy Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global HIV Therapy Market Sales by Application (2020-2033)
14.3 Global HIV Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global HIV Therapy Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 ViiV Healthcare
15.1.1 ViiV Healthcare Basic Information
15.1.2 ViiV Healthcare HIV Therapy Product Overview
15.1.3 ViiV Healthcare HIV Therapy Product Market Performance
15.1.4 ViiV Healthcare Business Overview
15.1.5 ViiV Healthcare SWOT Analysis
15.1.6 ViiV Healthcare Recent Developments
15.2 Gilead Sciences
15.2.1 Gilead Sciences Basic Information
15.2.2 Gilead Sciences HIV Therapy Product Overview
15.2.3 Gilead Sciences HIV Therapy Product Market Performance
15.2.4 Gilead Sciences Business Overview
15.2.5 Gilead Sciences SWOT Analysis
15.2.6 Gilead Sciences Recent Developments
15.3 Inc.
15.3.1 Inc. Basic Information
15.3.2 Inc. HIV Therapy Product Overview
15.3.3 Inc. HIV Therapy Product Market Performance
15.3.4 Inc. Business Overview
15.3.5 Inc. SWOT Analysis
15.3.6 Inc. Recent Developments
15.4 GlaxoSmithKline Plc
15.4.1 GlaxoSmithKline Plc Basic Information
15.4.2 GlaxoSmithKline Plc HIV Therapy Product Overview
15.4.3 GlaxoSmithKline Plc HIV Therapy Product Market Performance
15.4.4 GlaxoSmithKline Plc Business Overview
15.4.5 GlaxoSmithKline Plc Recent Developments
15.5 Merck Sharp and Dohme Corp.
15.5.1 Merck Sharp and Dohme Corp. Basic Information
15.5.2 Merck Sharp and Dohme Corp. HIV Therapy Product Overview
15.5.3 Merck Sharp and Dohme Corp. HIV Therapy Product Market Performance
15.5.4 Merck Sharp and Dohme Corp. Business Overview
15.5.5 Merck Sharp and Dohme Corp. Recent Developments
15.6 Bristol-Myers Squibb Company
15.6.1 Bristol-Myers Squibb Company Basic Information
15.6.2 Bristol-Myers Squibb Company HIV Therapy Product Overview
15.6.3 Bristol-Myers Squibb Company HIV Therapy Product Market Performance
15.6.4 Bristol-Myers Squibb Company Business Overview
15.6.5 Bristol-Myers Squibb Company Recent Developments
15.7 Janssen Pharmaceuticals
15.7.1 Janssen Pharmaceuticals Basic Information
15.7.2 Janssen Pharmaceuticals HIV Therapy Product Overview
15.7.3 Janssen Pharmaceuticals HIV Therapy Product Market Performance
15.7.4 Janssen Pharmaceuticals Business Overview
15.7.5 Janssen Pharmaceuticals Recent Developments
15.8 Inc.
15.8.1 Inc. Basic Information
15.8.2 Inc. HIV Therapy Product Overview
15.8.3 Inc. HIV Therapy Product Market Performance
15.8.4 Inc. Business Overview
15.8.5 Inc. Recent Developments
15.9 Boehringer Ingelheim International GmbH
15.9.1 Boehringer Ingelheim International GmbH Basic Information
15.9.2 Boehringer Ingelheim International GmbH HIV Therapy Product Overview
15.9.3 Boehringer Ingelheim International GmbH HIV Therapy Product Market Performance
15.9.4 Boehringer Ingelheim International GmbH Business Overview
15.9.5 Boehringer Ingelheim International GmbH Recent Developments
15.10 AbbVie Inc.
15.10.1 AbbVie Inc. Basic Information
15.10.2 AbbVie Inc. HIV Therapy Product Overview
15.10.3 AbbVie Inc. HIV Therapy Product Market Performance
15.10.4 AbbVie Inc. Business Overview
15.10.5 AbbVie Inc. Recent Developments
15.11 Genentech
15.11.1 Genentech Basic Information
15.11.2 Genentech HIV Therapy Product Overview
15.11.3 Genentech HIV Therapy Product Market Performance
15.11.4 Genentech Business Overview
15.11.5 Genentech Recent Developments
15.12 Inc.
15.12.1 Inc. Basic Information
15.12.2 Inc. HIV Therapy Product Overview
15.12.3 Inc. HIV Therapy Product Market Performance
15.12.4 Inc. Business Overview
15.12.5 Inc. Recent Developments
15.13 Mylan N.V.
15.13.1 Mylan N.V. Basic Information
15.13.2 Mylan N.V. HIV Therapy Product Overview
15.13.3 Mylan N.V. HIV Therapy Product Market Performance
15.13.4 Mylan N.V. Business Overview
15.13.5 Mylan N.V. Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global HIV Therapy Market Size by Type (M USD)
Table 4. Global HIV Therapy Market Size by Application (M USD)
Table 5. HIV Therapy Market Size Comparison by Region (M USD)
Table 6. Global HIV Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global HIV Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global HIV Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global HIV Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy as of 2024)
Table 11. Global Market HIV Therapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers HIV Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers HIV Therapy Product Type
Table 14. Global HIV Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. HIV Therapy Market Size Comparison by Region (M USD)
Table 26. Global HIV Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global HIV Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global HIV Therapy Sales by Region (2020-2033) & (K MT)
Table 29. Global HIV Therapy Sales Market Share by Region (2020-2033)
Table 30. North America HIV Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America HIV Therapy Sales by Country (2020-2033) & (K MT)
Table 32. North America HIV Therapy Sales by Type (K MT)
Table 33. North America HIV Therapy Market Size by Type (M USD)
Table 34. North America HIV Therapy Sales (K MT) by Type (2020-2033)
Table 35. North America HIV Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America HIV Therapy Sales by Application (K MT)
Table 37. North America HIV Therapy Market Size by Application (M USD)
Table 38. North America HIV Therapy Sales (K MT) by Application (2020-2033)
Table 39. North America HIV Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe HIV Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe HIV Therapy Sales by Country (2020-2033) & (K MT)
Table 42. Europe HIV Therapy Sales by Type (K MT)
Table 43. Europe HIV Therapy Market Size by Type (M USD)
Table 44. Europe HIV Therapy Sales (K MT) by Type (2020-2033)
Table 45. Europe HIV Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe HIV Therapy Sales by Application (K MT)
Table 47. Europe HIV Therapy Market Size by Application (M USD)
Table 48. Europe HIV Therapy Sales (K MT) by Application (2020-2033)
Table 49. Europe HIV Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific HIV Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific HIV Therapy Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific HIV Therapy Sales by Type (K MT)
Table 53. Asia-Pacific HIV Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific HIV Therapy Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific HIV Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific HIV Therapy Sales by Application (K MT)
Table 57. Asia-Pacific HIV Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific HIV Therapy Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific HIV Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America HIV Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America HIV Therapy Sales by Country (2020-2033) & (K MT)
Table 62. South America HIV Therapy Sales by Type (K MT)
Table 63. South America HIV Therapy Market Size by Type (M USD)
Table 64. South America HIV Therapy Sales (K MT) by Type (2020-2033)
Table 65. South America HIV Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America HIV Therapy Sales by Application (K MT)
Table 67. South America HIV Therapy Market Size by Application (M USD)
Table 68. South America HIV Therapy Sales (K MT) by Application (2020-2033)
Table 69. South America HIV Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa HIV Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa HIV Therapy Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa HIV Therapy Sales by Type (K MT)
Table 73. Middle East and Africa HIV Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa HIV Therapy Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa HIV Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa HIV Therapy Sales by Application (K MT)
Table 77. Middle East and Africa HIV Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa HIV Therapy Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa HIV Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global HIV Therapy Production (K MT) by Region(2020-2025)
Table 81. Global HIV Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global HIV Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global HIV Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America HIV Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe HIV Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan HIV Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China HIV Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global HIV Therapy Sales by Type (K MT)
Table 89. Global HIV Therapy Market Size by Type (M USD)
Table 90. Global HIV Therapy Sales (K MT) by Type (2020-2033)
Table 91. Global HIV Therapy Sales Market Share by Type (2020-2033)
Table 92. Global HIV Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global HIV Therapy Market Size Share by Type (2020-2033)
Table 94. Global HIV Therapy Sales (K MT) by Application
Table 95. Global HIV Therapy Market Size by Application(M USD)
Table 96. Global HIV Therapy Sales by Application (2020-2033) & (K MT)
Table 97. Global HIV Therapy Sales Market Share by Application (2020-2033)
Table 98. Global HIV Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global HIV Therapy Market Share by Application (2020-2033)
Table 100. Global HIV Therapy Sales Growth Rate by Application (2020-2033)
Table 101. ViiV Healthcare Basic Information
Table 102. ViiV Healthcare HIV Therapy Product Overview
Table 103. ViiV Healthcare HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. ViiV Healthcare Business Overview
Table 105. ViiV Healthcare SWOT Analysis
Table 106. ViiV Healthcare Recent Developments
Table 107. Gilead Sciences Basic Information
Table 108. Gilead Sciences HIV Therapy Product Overview
Table 109. Gilead Sciences HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Gilead Sciences Business Overview
Table 111. Gilead Sciences SWOT Analysis
Table 112. Gilead Sciences Recent Developments
Table 113. Inc. Basic Information
Table 114. Inc. HIV Therapy Product Overview
Table 115. Inc. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Inc. Business Overview
Table 117. Inc. SWOT Analysis
Table 118. Inc. Recent Developments
Table 119. GlaxoSmithKline Plc Basic Information
Table 120. GlaxoSmithKline Plc HIV Therapy Product Overview
Table 121. GlaxoSmithKline Plc HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. GlaxoSmithKline Plc Business Overview
Table 123. GlaxoSmithKline Plc Recent Developments
Table 124. Merck Sharp and Dohme Corp. Basic Information
Table 125. Merck Sharp and Dohme Corp. HIV Therapy Product Overview
Table 126. Merck Sharp and Dohme Corp. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Merck Sharp and Dohme Corp. Business Overview
Table 128. Merck Sharp and Dohme Corp. Recent Developments
Table 129. Bristol-Myers Squibb Company Basic Information
Table 130. Bristol-Myers Squibb Company HIV Therapy Product Overview
Table 131. Bristol-Myers Squibb Company HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Bristol-Myers Squibb Company Business Overview
Table 133. Bristol-Myers Squibb Company Recent Developments
Table 134. Janssen Pharmaceuticals Basic Information
Table 135. Janssen Pharmaceuticals HIV Therapy Product Overview
Table 136. Janssen Pharmaceuticals HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Janssen Pharmaceuticals Business Overview
Table 138. Janssen Pharmaceuticals Recent Developments
Table 139. Inc. Basic Information
Table 140. Inc. HIV Therapy Product Overview
Table 141. Inc. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Inc. Business Overview
Table 143. Inc. Recent Developments
Table 144. Boehringer Ingelheim International GmbH Basic Information
Table 145. Boehringer Ingelheim International GmbH HIV Therapy Product Overview
Table 146. Boehringer Ingelheim International GmbH HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Boehringer Ingelheim International GmbH Business Overview
Table 148. Boehringer Ingelheim International GmbH Recent Developments
Table 149. AbbVie Inc. Basic Information
Table 150. AbbVie Inc. HIV Therapy Product Overview
Table 151. AbbVie Inc. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. AbbVie Inc. Business Overview
Table 153. AbbVie Inc. Recent Developments
Table 154. Genentech Basic Information
Table 155. Genentech HIV Therapy Product Overview
Table 156. Genentech HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Genentech Business Overview
Table 158. Genentech Recent Developments
Table 159. Inc. Basic Information
Table 160. Inc. HIV Therapy Product Overview
Table 161. Inc. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Inc. Business Overview
Table 163. Inc. Recent Developments
Table 164. Mylan N.V. Basic Information
Table 165. Mylan N.V. HIV Therapy Product Overview
Table 166. Mylan N.V. HIV Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Mylan N.V. Business Overview
Table 168. Mylan N.V. Recent Developments
List of Figures
Figure 1. Product Picture of HIV Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Therapy Market Size (M USD), 2024-2033
Figure 5. Global HIV Therapy Market Size (M USD) (2020-2033)
Figure 6. Global HIV Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global HIV Therapy Product Life Cycle
Figure 13. HIV Therapy Sales Share by Manufacturers in 2024
Figure 14. Global HIV Therapy Revenue Share by Manufacturers in 2024
Figure 15. HIV Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market HIV Therapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by HIV Therapy Revenue in 2024
Figure 18. Industry Chain Map of HIV Therapy
Figure 19. Global HIV Therapy Market PEST Analysis
Figure 20. Global HIV Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global HIV Therapy Market Size by Region
Figure 27. Global HIV Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global HIV Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America HIV Therapy Market Size (M USD) by Country
Figure 33. USA HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada HIV Therapy Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada HIV Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico HIV Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico HIV Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America HIV Therapy Market Size (M USD)by Type
Figure 40. North America HIV Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe HIV Therapy Market Size (M USD) by Country
Figure 45. Germany HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe HIV Therapy Market Size (M USD) by Type
Figure 56. Europe HIV Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific HIV Therapy Market Size (M USD) by Country
Figure 61. China HIV Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan HIV Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea HIV Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India HIV Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia HIV Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia HIV Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific HIV Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific HIV Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America HIV Therapy Market Size (M USD) by Country
Figure 77. Brazil HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America HIV Therapy Market Size (M USD) by Type
Figure 84. South America HIV Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa HIV Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa HIV Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa HIV Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa HIV Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa HIV Therapy Market Size (M USD) by Application
Figure 101. Global HIV Therapy Production Market Share by Region (2020-2025)
Figure 102. North America HIV Therapy Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe HIV Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan HIV Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. China HIV Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global HIV Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of HIV Therapy by Type (2020-2033)
Figure 109. Sales Market Share of HIV Therapy by Type in 2024
Figure 110. Market Size Share of HIV Therapy by Type (2020-2033)
Figure 111. Market Size Share of HIV Therapy by Type in 2024
Figure 112. Global HIV Therapy Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global HIV Therapy Market Size by Application(M USD)
Figure 115. Global HIV Therapy Market Share by Application
Figure 116. Global HIV Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global HIV Therapy Sales Market Share by Application in 2024
Figure 118. Global HIV Therapy Market Share by Application (2020-2033)
Figure 119. Global HIV Therapy Market Share by Application in 2024
Figure 120. Global HIV Therapy Sales Growth Rate by Application (2020-2033)